Ares Financial Consulting’s Insmed INSM Stock Holding History

Ares Financial Consulting’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$533	Buy	+5	New	+$605	﹤0.01%	1083

Other funds holding INSM

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Ares Financial Consulting's INSM Position: Q2 2026 in Review

Ares Financial Consulting opened a new position in Insmed (INSM) in Q2 2026: 5 shares worth $533. The stake represents ﹤0.01% of the portfolio and ranks #1083 among its holdings.

233 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Ares Financial Consulting held 5 shares of Insmed worth $533 as of Q2 2026.
Insmed was a new Ares Financial Consulting position in Q2 2026.
Insmed made up ﹤0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #1083 holding.
233 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.